Profound Medical Corp. (PROF) Q2 2023 Earnings Call Transcript


Profound Medical Corp. (NASDAQ:PROF) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET

Company Participants

Stephen Kilmer – IR

Arun Menawat – CEO

Rashed Dewan – CFO

Conference Call Participants

Rahul Sarugaser – Raymond James

Nelson Cox – Lake Street Capital Markets

Ben Haynor – Alliance Global Partners

Joshua Jennings – TD Cowen

Operator

Good day and thank you for standing by. Welcome to the Profound Medical Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to Stephen Kilmer, Investor Relations. Please go ahead.

Stephen Kilmer

Thank you. Good afternoon everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws of the United States and Canada.

All forward-looking statements are based on Profound’s current beliefs, assumptions, and expectations and relate to, among other things, expectations regarding the efficacy of the company’s treatment technologies, results of future clinical trials, the ability to obtain coding and/or reimbursement from third-party payers, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance, and future commitments.

Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. No forward-looking statement can be guaranteed.

Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. Profound undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required by law.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *